Butanyl

Quick links to important sections

Butanyl

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Butanyl

Quick Facts

Property Description
Active ingredient Terbutaline sulfate
Form Tablet, oral solution, nebulizer solution, solution for injection
Pharmacological class Selective beta2-adrenergic receptor agonist
Origin Synthetic compound
General purpose Bronchodilation (Airway widening)

Butanyl: Definition and Pharmacological Classification

Butanyl is a pharmaceutical preparation whose medicinal effect originates entirely from the active ingredient, Terbutaline sulfate. The drug is classified as a sympathomimetic agent, specifically recognized as a selective beta2-adrenergic receptor agonist. This classification reflects its targeted action on bronchial smooth muscle receptors.

This establishes the fundamental scientific identity of the medicine. Terbutaline is a synthetic compound, derived from phenylethanolamine, and is designed as a single-ingredient product. Its core purpose is defined by its selective action: preferentially stimulating the beta2-adrenergic receptors found in the bronchial smooth muscle within the lungs. The active ingredient, Terbutaline, is recognized for its significance in global public health frameworks.


Composition, Forms, and General Therapeutic Purpose

Butanyl's primary function is that of a bronchodilator, meaning its general therapeutic purpose is to relax the muscles around the air passages to restore easier airflow. The medication is presented in diverse dosage forms, including tablets, oral solution, nebulizer solution, and solution for injection.

The composition of each form consists of the precise dose of Terbutaline sulfate suspended within an appropriate aqueous vehicle for liquids, or a solid vehicle for tablets and powders. This flexibility in dosage forms allows the medication to be administered via the oral route, inhalational route, or subcutaneous injection. The resulting physiological action—the relaxation of bronchial smooth muscle—is the core mechanism that achieves the general benefit of opening of airways for patients experiencing restricted breathing. This same principle of smooth muscle relaxation also underpins its specialized use as a tocolytic agent, where Terbutaline acts to relax the smooth muscle of the uterus for specialized maternal care.

Regulatory References

  1. WHO Model Lists of Essential Medicines
  2. Terbutaline: MedlinePlus Drug Information

What side effects are possible with Butanyl?

Possible Side Effects and Safety Information

The safety profile of Butanyl (Terbutaline sulfate) is defined by adverse reactions consistent with its classification as a selective beta-2 adrenergic receptor agonist. Officially documented effects are categorized by frequency and the body system affected, according to regulatory standards.


Frequency-Classified Adverse Reactions

Adverse reactions are formally categorized based on incidence rates found in regulatory sources:

Classification Examples of Reactions
Very Common (geq1/10) Tremor, Headache
Common (geq1/100 to <1/10) Tachycardia, Palpitations, Muscle Spasms, Hypokalemia
Not Known Arrhythmias, Myocardial Ischemia, Hypersensitivity reactions

These effects are grouped across System-Organ Classes including Nervous System Disorders, Cardiac Disorders, Metabolism and Nutrition Disorders, and Musculoskeletal Disorders.


Serious Adverse Reactions and Key Constraints

The official labeling highlights specific serious risks. Clinically significant cardiovascular events are documented, including the potential for Myocardial Ischemia and Arrhythmias. Rare but life-threatening reactions such as Paradoxical Bronchospasm and severe Hypersensitivity reactions are also noted.

Population-Specific Safety: The oral form of Butanyl is contraindicated for the treatment of preterm labor (tocolysis). Caution is strictly advised for individuals with pre-existing cardiovascular conditions, such as ischemic heart disease or hypertension, due to the potential for significant cardiovascular effects. Furthermore, common adverse reactions like tremor and palpitations are often observed to diminish or reverse spontaneously within the first one to two weeks of treatment.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdosage with Butanyl (Terbutaline sulfate) is officially documented by a range of manifestations reflecting excessive stimulation of the sympathetic system. Documented clinical signs typically include tachycardia (fast heart rate), palpitations, pronounced tremor or shaking, headache, and anxiety. Other regulator-listed signs can include nausea, vomiting, dizziness, and tonic muscle cramps.

Severe or life-threatening presentations are recognized in the official profile. These can include potentially fatal cardiac arrhythmias, a severe drop in blood pressure (hypotension), seizures, and collapse. Official physiological findings also include metabolic disturbances such as hyperglycaemia (high blood sugar) and hypokalemia (low blood potassium) due to internal redistribution.

Immediate Emergency Actions are mandated when severe manifestations occur. Call emergency services immediately if any person is experiencing a seizure, has trouble breathing, or cannot be awakened. Medical attention must be sought immediately if symptoms worsen or the prescribed product becomes less effective. Management in a healthcare setting requires continuous monitoring of heart rate, blood pressure, acid-base balance, and electrolytes. A cardioselective beta-receptor blocking agent is the preferred antidote, though its use requires caution due to the risk of inducing bronchospasm.

Therapeutic Uses of Butanyl

What Butanyl treats: main uses and benefits

Butanyl is a pharmacological treatment primarily utilized for its properties as a bronchodilator. It belongs to the class of medications known as selective beta-2 adrenergic agonists. Its therapeutic role focuses on the management of respiratory conditions characterized by airflow obstruction.

Primary Indications

The medication is indicated for the symptomatic relief and prevention of bronchospasm in patients with various respiratory disorders. These primarily include:

  • Bronchial Asthma: It is used to manage both acute symptoms and the long-term maintenance of airway patency in patients diagnosed with asthma.
  • Chronic Obstructive Pulmonary Disease (COPD): It assists in treating the reversible component of airway obstruction associated with chronic bronchitis and emphysema.
  • Exercise-Induced Bronchospasm: It may be used to prevent the narrowing of airways triggered by physical exertion.

Mechanism of Action and Benefits

Butanyl functions by targeting specific receptors located in the smooth muscles of the lungs. By activating these beta-2 receptors, the medication facilitates the relaxation of the bronchial tubes. This process leads to several clinical benefits:

  • Airway Dilation: The relaxation of smooth muscles widens the airways, making it easier for air to pass into and out of the lungs.
  • Symptom Alleviation: By reducing airway resistance, it helps alleviate common symptoms such as wheezing, shortness of breath, and chest tightness.
  • Rapid Response: In many formulations, the medication acts quickly to provide relief during periods of acute respiratory distress.
  • Improved Respiratory Function: Consistent management of airflow obstruction can contribute to a better quality of life and improved tolerance for daily physical activities.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Butanyl?

This section outlines the official eligibility requirements and restrictions for Butanyl based on regulatory labeling.

Absolute Contraindications

Butanyl is contraindicated (must not be used) in patients with the following conditions or histories, as defined in the official prescribing information:

  • Known Hypersensitivity to Butanyl or any of its inactive ingredients.
  • History of Seizures or any condition that significantly lowers the seizure threshold.
  • Current or prior diagnosis of bulimia nervosa or anorexia nervosa.

Use in Specific Populations

Regulatory documents mandate special considerations or restrictions for certain groups:

  • Age: Safety and effectiveness for pediatric patients (under 18 years) have not been established. Use in the elderly (geriatric population) requires cautious dose selection.
  • Organ Function: Patients with severe hepatic impairment or severe renal impairment may be required to use a significantly reduced dosage, or their use may be restricted due to the drug’s clearance profile.
  • Pregnancy and Lactation: Use during pregnancy is generally not recommended due to potential fetal risk, and use while breastfeeding is also not recommended as the drug is known to be excreted in human milk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Co-administration of Butanyl (Terbutaline sulfate) with other medicinal products can result in documented pharmacodynamic interactions that alter the effect of one or both agents, as described in regulatory prescribing information.

Contraindicated and Restricted Combinations

Beta-adrenergic receptor blocking agents, especially non-selective blockers, may partially or totally inhibit the bronchodilating effect of Butanyl. This combination is typically avoided due to the potential for severe bronchospasm. Co-administration with other Sympathomimetic Agents is not recommended because of the risk of a deleterious augmented effect on the cardiovascular system.

Pharmacodynamic Interactions

Interactions involving vascular potentiation are documented with Monoamine Oxidase Inhibitors (MAOIs) and Tricyclic Antidepressants (TCAs). Official labeling advises caution when Butanyl is administered with these agents, or within two weeks of their discontinuation, establishing a mandatory timing rule.

Separately, Potassium Depleting Agents like Non-Potassium Sparing Diuretics, Xanthine Derivatives, and Corticosteroids can potentiate the hypokalemic effect associated with beta2-agonist therapy. The use of Halogenated Anaesthetics is discouraged during treatment due to an increased risk of cardiac arrhythmias. No specific drug-food, alcohol, or herbal product interactions are documented that mandate administration restrictions.

Mechanism of Action

How Butanyl Works

Butanyl acts as an inhibitor of the MEK-1 (Mitogen-Activated Protein Kinase Kinase 1) enzyme

. This enzyme is a core component of the intracellular RAS/RAF/MEK/ERK signaling cascade, which regulates fundamental cellular processes.

Butanyl mediates its effect by binding to the allosteric site of MEK-1. This interaction induces a conformational change that limits the subsequent phosphorylation cascade involving ERK1/2. The suppression of ERK1/2 activity results in the modulation of inflammatory signaling pathways and decreased activity of transcription factors, including NF-kappaB.

This cascade inhibition leads to a reduction in the transcription and translation of pro-inflammatory cytokines (e.g., IL-6, TNF-alpha) and chemokines. Furthermore, Butanyl modulates the expression of adhesion molecules. These specific molecular events collectively define the compound's mode of action entirely within the biochemical and physiological domains.

Dosage and Administration Information

Butanyl (Terbutaline sulfate) is administered via three primary routes for managing breathing difficulty. The dosage forms include oral tablets (2.5 mg and 5 mg), subcutaneous solution for injection, and inhalation powder or solution.

Official Labeled Dosing Regimens

Administration Route Standard Adult Dose Maximum Limit
Oral 5 mg three times daily (TID). 15 mg per 24 hours.
Subcutaneous (SC) 0.25 mg, administered into the lateral deltoid area. 0.5 mg per 4-hour period.
Inhalation 0.5 mg (one inhalation) as required. Not more than 4 inhalations per 24 hours.

Oral doses should be taken at approximately six-hour intervals during the patient's waking hours. For acute situations, a second SC injection of 0.25 mg may be administered 15 to 30 minutes after the initial dose if substantial improvement is not achieved.

Age-Specific Use and Constraints

Oral administration is not recommended for children under 12 years of age. For adolescents aged 12 to 15 years, the maximum oral dosage is restricted to 7.5 mg per 24 hours. Patients are instructed not to increase the dose or frequency without professional re-evaluation. If a scheduled oral dose is missed, patients should skip the missed dose and resume the regular schedule without doubling up.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Butanyl

Evidence for Use in Managing Bronchospasm

This section summarizes the structure of the clinical evaluation for Butanyl (Terbutaline sulfate) for conditions that narrow the airways, such as asthma and COPD. The research exploring use for conditions that involve breathing difficulties has primarily involved Randomized Controlled Trials (RCTs) and systematic reviews.

Researchers focused on monitoring pulmonary function through objective measurements, such as the amount of air a person can force out in one second ( FEV1), and tracked patient-reported outcomes describing perceived discomfort. Findings describe patterns observed in the studies related to pulmonary function, consistent with the changes measured in the trials. However, uncertainty is documented regarding some aspects, including limited high-quality information for long-term outcomes and the sustained consistency of the observed response with regular use.


Evidence for Specialized Use in Managing Uterine Contractions

The research base for this specialized use consists of Randomized Controlled Trials and systematic reviews evaluated in contexts involving acute episodes of premature uterine contractions. Studies monitored women between 24 and 36 weeks of pregnancy.

Research examined outcomes related to physical discomfort and systemic imbalance, such as measures of delay of delivery (e.g., whether birth was postponed by 24 or 48 hours) and neonatal outcomes (e.g., gestational age at birth). The findings describe patterns indicating the medication was studied for its acute effect on uterine contractions. Follow-up durations were limited, and the evidence is limited or shows variability when examining sustained changes in neonatal health parameters.


Consistency and Gaps in the Research Record

Evidence quality varies across studies, particularly in the specialized obstetric domain where trials have often had modest sample sizes. The scientific literature notes that findings were mixed concerning the ability of the medication to provide a lasting change in severe outcomes. Research indicates that data remain insufficient regarding long-term outcomes for both indications and robust comparative evidence against certain newer therapies.

Frequently Asked Questions (FAQ)

Common questions about Butanyl (FAQ)


Q: How long does it typically take for Butanyl to start working?

The time it takes for the effects to begin can depend on how the medicine is administered. Regulatory information describes that the inhaled form is designed to start working most quickly, while the oral tablet forms generally take longer to produce their effect.


Q: Is Butanyl the same type of medicine as [similar common drug]? What is the difference?

Butanyl (Terbutaline sulfate) is officially described as a beta-adrenergic receptor agonist. This classification places it in a group of medicines known as bronchodilators, which are used to relax the muscles around the airways. Its specific action is defined by this chemical classification, distinguishing it from drugs in other categories.


Q: Are there different strengths or formulations of Butanyl available?

Yes, official prescribing information lists different ways this medicine is supplied. It is available as oral tablets, a solution prepared for subcutaneous (under the skin) injection, and a powder or solution intended for inhalation.


Q: Why does the packaging for Butanyl include a specific warning about [general topic, e.g., liver function]?

Official labeling highlights the potential for the drug to affect metabolism. Specifically, it includes warnings about the potential for changes in blood glucose levels. This potential effect is a factor that is generally reviewed with a healthcare provider, especially for individuals with conditions like diabetes.


Q: Does Butanyl interact with common herbal supplements like St. John's Wort?

According to official regulatory prescribing information, no specific interactions with herbal products are documented that require mandated administration restrictions. Information for healthcare professionals highlights the importance of reviewing all supplements a patient may be using.


Q: Can Butanyl be used by women who are planning pregnancy?

The official documents mention specific uses and contraindications related to pregnancy, particularly noting that the oral form is generally contraindicated for use in preterm labor. Due to these potential effects, official documents establish that the decision to use the drug before and during pregnancy requires weighing the potential benefits and risks with a healthcare provider.


Q: How does Butanyl interact with alcohol?

Official regulatory prescribing information for Butanyl does not document a specific interaction with alcohol that requires an administration restriction or mandatory warning. Regulatory labeling does not mandate administration restrictions regarding alcohol.


Q: Is the research evidence for Butanyl considered strong?

Clinical trial summaries describe patterns consistent with the drug's intended purpose. Regulatory reviews of this evidence note that while the drug's acute effects have been studied, the evidence is described as limited concerning the consistency of the response over the long term, particularly for specialized uses.


Q: Do I need to take Butanyl every day, or only when needed?

The instructions for use vary based on the form of the medicine. The official dosing schedule for the oral tablet is described as a routine maintenance use taken multiple times daily. In contrast, the subcutaneous injection and inhalation forms are generally described for use as needed for acute symptoms.


Q: Can Butanyl be taken with commonly used over-the-counter pain relievers?

The official documentation does not list specific common over-the-counter pain relievers (like ibuprofen or acetaminophen) as contraindicated. However, the regulatory documents caution against combining Butanyl with other adrenergic agents due to the potential for augmented effects on the heart.


Q: Can Butanyl affect my ability to drive or operate machinery?

The drug's safety profile includes side effects that affect the nervous system, such as tremor, headache, and dizziness. Regulatory information advises caution because these effects may impact a patient’s ability to drive or safely operate complex equipment.


Q: Does Butanyl require any special monitoring by a healthcare provider?

Yes, official safety information recommends monitoring for certain physiological changes. Specifically, monitoring of serum potassium levels and blood glucose levels is recommended in certain patient situations to ensure safe use of the medicine.


Q: Is Butanyl a type of narcotic or controlled substance?

Butanyl (Terbutaline sulfate) is classified as a medicine that is not scheduled under regulatory acts for controlled substances in the United States. It is not considered a narcotic.


Q: Does Butanyl stay in your system for a long time after stopping use?

Pharmacokinetic data available in the official labeling describes the drug’s elimination from the body. This information indicates that Butanyl generally has a short half-life, meaning it is quickly cleared from the body.


Q: Can people with [broad common condition, e.g., high blood pressure] use Butanyl?

Official regulatory warnings advise strict caution for individuals who have pre-existing cardiovascular conditions, such as hypertension (high blood pressure) or ischemic heart disease. This is due to the potential for the drug to cause significant cardiovascular effects.


Q: What happens if a scheduled use of Butanyl is missed?

Instructions provided in official patient information for the oral form state that if a dose is missed, the patient should skip that dose. They should then resume the regular schedule without taking a double dose to compensate.


Q: Can Butanyl affect blood sugar levels?

Yes, official labeling notes that Butanyl can have a hyperglycemic effect, meaning it may cause an increase in blood sugar. This effect is a factor for consideration, especially for those who have diabetes.


Q: What makes Butanyl different from other drugs for [class of condition]?

Butanyl belongs to the class of beta-adrenergic receptor agonists. Its mechanism of action is defined by its ability to stimulate receptors to relax the smooth muscles, which in turn helps to open the airways. This is what classifies it functionally among medicines used for conditions that narrow the airways.


Q: Is Butanyl available as a generic medicine?

Yes, regulatory records confirm that the oral tablet formulation of Butanyl (Terbutaline sulfate) is approved by the relevant authorities and is available in generic form.


Q: Can Butanyl affect kidney function?

Official drug information contains specific dosage adjustments for patients with renal impairment (reduced kidney function). This guidance suggests that the body's clearance of the drug may be affected by the health of the kidneys.


Q: Are there specific groups of people where Butanyl has been studied more extensively?

Research summaries describe specific populations where the drug was studied in clinical trials. These groups include adolescents, adults with conditions that narrow the airways, and, for specialized use, pregnant women in specific trimesters.


Q: What are the general expectations for benefits when using Butanyl?

The drug is indicated for the purpose of helping to prevent and relieve symptoms associated with narrowed airways. Clinical study outcomes describe patterns related to the measurable changes in pulmonary function and symptom severity.


Q: Can Butanyl cause digestive upset?

Yes, official regulatory documents detailing adverse reactions include reports of gastrointestinal effects. Examples of these documented effects include common issues such as nausea and heartburn.


Q: What factors are generally considered when deciding if Butanyl is appropriate?

Official safety documents list several factors that a healthcare provider typically considers. These include a patient's medical history regarding conditions such as pre-existing cardiovascular issues, diabetes, seizure disorders, or an overactive thyroid.


Q: Are there specific non-medical substances that are known to interact with Butanyl?

Regulatory guidance suggests that combining Butanyl with non-medical substances like high amounts of caffeine may be inadvisable. This combination has the potential to amplify cardiovascular effects, such as increasing heart rate and blood pressure.


Q: Do younger adults use Butanyl for the same reasons as older adults?

Yes, the official indication (purpose of the drug) is described consistently for the treatment of bronchospasm in patients 12 years of age and older. This suggests that the primary condition the drug treats is the same across this age range.


Q: What is the difference between the 'active' and 'inactive' ingredients in Butanyl?

The active ingredient, Terbutaline sulfate, is the component of the medicine that produces the intended effect in the body. Inactive ingredients are included for the purposes of compounding and forming the tablet or solution, such as providing bulk or ensuring stability.

How should Butanyl be stored and disposed of?

How to Store and Dispose of Butanyl

Butanyl (Terbutaline sulfate) must be stored under specific environmental constraints to maintain its stability and effectiveness, as defined by regulatory labeling.

Storage Requirements

Storage Factor Official Requirement
Temperature Store at Controlled Room Temperature, 20 C to 25 C (68 F to 77 F). Do not freeze.
Protection Keep protected from light and moisture. Store in the original, tightly closed container.
Stability Opened injection vials must be used immediately; opened nebulizer units should be used within 24 hours.
Child Safety Keep the medication out of the reach and sight of children.

Disposal Instructions

Unused or expired Butanyl must be disposed of according to local and state pharmaceutical waste regulations. Consult a healthcare professional or pharmacist for disposal guidance. Needles and sharps used with the injection must be placed immediately in an FDA-cleared sharps disposal container. The product should not be poured into drains or watercourses.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Butanyl found in:

A-Z Index: